In vivo Comparison of the Biodistribution and Toxicity of InP/ZnS Quantum Dots with Different Surface Modifications
Received 6 December 2019
Accepted for publication 10 March 2020
Published 20 March 2020 Volume 2020:15 Pages 1951—1965
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Yan Shen
Li Li,1,2 Yajing Chen,1 Gaixia Xu,2,3 Dongmeng Liu,1 Zhiwen Yang,1 Tingting Chen,1 Xiaomei Wang,1 Wenxiao Jiang,1 Dahui Xue,1 Guimiao Lin1
1Base for International Science and Technology Cooperation: Carson Cancer Stem Cell Vaccines R&D Center, Shenzhen Key Laboratory of Synthetic Biology, Department of Physiology, School of Basic Medical Sciences, Shenzhen University, Shenzhen 518055, People’s Republic of China; 2Key Laboratory of Optoelectronics Devices and Systems of Ministry of Education/Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, People’s Republic of China; 3Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Health Science Center, Shenzhen University, Shenzhen 518055, People’s Republic of China
Correspondence: Guimiao Lin
School of Basic Medical Sciences, Shenzhen University Health Sciences Center, Shenzhen 518060, People’s Republic of China
Tel/ Fax +86-755-86671903
Email [email protected]
Introduction: Indium phosphide (InP) quantum dots (QDs) have shown a broad application prospect in the fields of biophotonics and nanomedicine. However, the potential toxicity of InP QDs has not been systematically evaluated. In particular, the effects of different surface modifications on the biodistribution and toxicity of InP QDs are still unknown, which hinders their further developments. The present study aims to investigate the biodistribution and in vivo toxicity of InP/ZnS QDs.
Methods: Three kinds of InP/ZnS QDs with different surface modifications, hQDs (QDs-OH), aQDs (QDs-NH2), and cQDs (QDs-COOH) were intravenously injected into BALB/c mice at the dosage of 2.5 mg/kg BW or 25 mg/kg BW, respectively. Biodistribution of three QDs was determined through cryosection fluorescence microscopy and ICP-MS analysis. The subsequent effects of InP/ZnS QDs on histopathology, hematology and blood biochemistry were evaluated at 1, 3, 7, 14 and 28 days post-injection.
Results: These types of InP/ZnS QDs were rapidly distributed in the major organs of mice, mainly in the liver and spleen, and lasted for 28 days. No abnormal behavior, weight change or organ index were observed during the whole observation period, except that 2 mice died on Day 1 after 25 mg/kg BW hQDs treatment. The results of H&E staining showed that no obvious histopathological abnormalities were observed in the main organs (including heart, liver, spleen, lung, kidney, and brain) of all mice injected with different surface-functionalized QDs. Low concentration exposure of three QDs hardly caused obvious toxicity, while high concentration exposure of the three QDs could cause some changes in hematological parameters or biochemical parameters related to liver function or cardiac function. More attention needs to be paid on cQDs as high-dose exposure of cQDs induced death, acute inflammatory reaction and slight changes in liver function in mice.
Conclusion: The surface modification and exposure dose can influence the biological behavior and in vivo toxicity of QDs. The surface chemistry should be fully considered in the design of InP-based QDs for their biomedical applications.
Keywords: InP/ZnS quantum dots, surface chemistry, in vivo, biodistribution, nanotoxicology
In the past few years, nanomaterials have attracted widespread interest owing to their unique magnetic, optical, thermal or conductive properties. Quantum dots (QDs) are composed of group Ⅱ-Ⅳ or Ⅲ-Ⅴ elements with the diameter of 1–10 nm. As a kind of interesting semiconductor nanomaterials, QDs have many unique and electronic properties such as broad excitation spectra, narrow emission spectra, tunable size-dependent emission peaks, strong signal intensity and light bleaching resistance.1–3 These properties make QDs very promising tools in photoelectronic devices, biomedical and pharmaceutical fields.4 According to the literature, QDs could be used in targeted drug delivery,5 multiplexed bioimaging,6 diagnostic,7 luminescent sensors8,9 and nanophotocatalysts10,11 applications after they coupled with different molecules. Despite the numerous benefits provided by QDs, people still have doubts about their potential harmful health effects, which are related to the heavy metals such as Cd, Pb, As, and Te in these materials.12,13 Considering the inherent toxicity of Cd-based QDs, it is critical to find other kinds of safer QDs.
Among the Cd-free alternatives, indium phosphide (InP) QDs have shown great potential as a replacement for Cd-based QDs. Because InP QDs do not contain heavy metal elements, they show stable quantum yield and size-tunable photoluminescence (PL) emission from visible to near-infrared (NIR) range, and InP QDs are beneficiary in biological applications.14,15 For example, Zhang et al carried out in vivo imaging of tumor-bearing nude mice with silica medium composite probe encapsulated InP/ZnS QDs and found that the composite probe had excellent tumor targeting and fluorescence imaging capabilities.16 More importantly, different from the ionic bond in CdSe QDs, the covalent bond in InP QDs is stronger and more robust, which makes them less toxicity.17,18 Some studies have proved the biosafety of InP QDs. For instance, Yaghini et al found that InP QDs mainly accumulated in the liver and spleen of rats, with no obvious organ damage, histopathological lesions or serum biochemical changes when the rats were injected intravenously with InP QDs at the dose of 12.5mg/kg body weight (BW) or 50mg/kg BW.19 Brunetti et al found that the toxicity of InP/ZnS QDs was much lower than that of CdSe/ZnS QDs by comparing their toxicity in vitro and in vivo (animal model Drosophila), and they considered InP/ZnS QDs were safer alternatives to CdSe/ZnS QDs.20 However, some published studies have provided evidence of biological damage caused by InP QDs. For example, Yamazaki et al investigated the survival of the Syrian golden hamster for 2 years, during which they were given 3 mg/kg InP particles intratracheally twice a week for 8 weeks. Severe pulmonary inflammation and localized bronchioloalveolar cell proliferation was observed after the last administration.21 Chen et al reported InP/ZnS QDs could cause the deformation and death during the development of Chinese rare minnow embryos, although the effects were weaker than Cd-based QDs and CuInS/ZnS QDs.22
As we all know, QDs are possibly exposed to organisms through many routes, including lung inhalation, ingestion, skin contact, and even intravenous injection during the process of production, application and wasting.23 Then, they may circulate, metabolize, excrete or accumulate in the body, and produce varying levels of biological toxic effects on organisms. The in vivo biological features of QDs mainly depend on the physicochemical characteristics such as elemental composition, particle size, surface charge, surface chemical properties.24–26 Du et al reported that PEG functionalization could reduce the accumulation of CdTe QDs in liver and kidney, and also decrease the oxidative stress variation.27 Since the majority of QDs are composed of toxic substances, shells or macromolecules are often coated on the surface in order to reduce the biotoxicity.28,29 In addition, researchers hope the QDs could be eliminated from the body over time, rather than being broken down or accumulated in organs for a long time. Thus, the in vivo distribution and toxicity of QDs with different physicochemical properties need to be deeply addressed before wide-scale biological application of QDs. However, there are limited reports on the toxicity of InP QDs, and most of them focus on toxicity studies using in vitro cell model or simple model organisms, which may hinder the biomedical application of InP QDs.
In the present study, in order to evaluate the in vivo distribution and biotoxicity of InP/ZnS QDs with different surface modifications, three kinds of commercially available InP/ZnS QDs, including hydroxylated QDs (hQDs), amino QDs (aQDs), and carboxylic QDs (cQDs) were injected intravenously into mice, respectively. Mice were sacrificed at 1, 3, 7, 14 and 28 days’ post-exposure. By comparing the behavior, weight, organ coefficient, hematological parameters, serum biochemical parameters, biodistribution and organ histopathology of the animal models in different groups, the effects of different surface functional groups on the toxicity of InP/ZnS QDs were demonstrated. Our study may provide a better understanding of the effects of surface chemistry on QDs toxicity at the animal level and also facilitate the synthesis of safer QDs in biomedical applications.
Materials and Methods
Characterization of InP/ZnS QDs
InP/ZnS QDs used in this study were prepared by Najing Tech Company, China. Prior to be used in our experiments, the surface of QDs was modified with hydroxyl, amino and carboxyl groups, respectively. Finally, three water-soluble InP/ZnS QDs, including hydroxylated QDs (hQDs), amino QDs (aQDs), and carboxylic QDs (cQDs) were obtained. The size and morphology of the three QDs were characterized by transmission electron microscopy (TEM) (HT7700, HITACHI, Japan) with an acceleration voltage of 80 kV. Zeta potential and hydrodynamic size distribution of the three QDs were characterized by zeta potential and particle size analyzer (Brookhaven Instruments Inc., USA). Fluorescence spectra and absorption spectra were measured by fluorescence spectrophotometer (F-4600, HITACHI, Japan) and UV/Vis spectrophotometer (DU720, Beckman Coulter Inc., USA), separately. Moreover, the concentration of In in the three InP/ZnS QDs solution was quantitatively measured by inductively coupled plasma mass spectrometry (ICP-MS, PerkinElmer, USA) and the exposure dose of QDs were calculated based on the mass concentration of the In.
Healthy female BALB/c mice (6 weeks old) were purchased from the Medical Laboratory Animal Center of Guangdong Province. The mice were raised in a ventilated, temperature-controlled and standardized sterile animal room with a 12 hr day/light circle at Shenzhen University. The mice were allowed to adapt the animal facility for 7 days prior to experimentation and had free access to food and water. All procedures used in this study were conducted in accordance with the Guide for the Care and Use of Laboratory Animals Center of Shenzhen University and approved by the Experimental Animal Ethics Committee of Shenzhen University (Permit No.2017011).
Animal Treatments and Sample Collection
Mice were randomly divided into 7 groups according to the kinds and doses of QDs exposed, as follows: (1) hQDs high-dose group (hQDs-H), treated with 25 mg/kg BW hQDs; (2) hQDs low dose group (hQDs-L), treated with 2.5 mg/kg BW hQDs; (3) aQDs high-dose group (aQDs-H), treated with 25 mg/kg BW aQDs; (4) aQDs low dose group (aQDs-L), treated with 2.5 mg/kg BW aQDs; (5) cQDs high-dose group (cQDs-H), treated with 25 mg/kg BW cQDs; (6) cQDs low dose group (cQDs-L), treated with 2.5 mg/kg BW cQDs; (7) control group, treated with physiological saline. QDs were diluted in physiological saline and were injected intravenously into mice through the tail vein with a volume of 100 μL per mouse. Mice in the control group were treated with the same volume of physiological saline. Observation of survival, food intake, fur, behavior, mental status, urine, feces and body weight were recorded daily for each mouse. At predetermined time points (1, 3, 7, 14 and 28 days), seven mice from each group were anesthetized using isoflurane. Blood was harvested from the posterior orbital venous plexus of mice. About 50 μL of blood was collected with anticoagulant tubes for routine blood test. The rest of the blood was collected with procoagulant tube for biochemical analysis. Both routine blood test and biochemical analysis were operated immediately. Then, the mice were sacrificed by cervical dislocation and the main organs (heart, liver, spleen, lung, kidney, and brain) were collected. Some pieces were fixed in tissue fixative (Wexis, China) for subsequent evaluation of histopathological changes. Some pieces were embedded in optimal cutting temperature compound (OCT, Sakura Finetek, USA) for tissue fluorescence imaging. Other fresh tissue samples were stored at −80°C for measurements of In levels in organs.
Cryosection Fluorescence Microscopy
Mice were administered intravenously with QDs with different surface functional groups at 25 mg/kg BW or 2.5 mg/kg BW and were sacrificed at various post-injection time points. The heart, liver, spleen, lung, kidney and brain was harvested, embedded into OCT compound and frozen at −80°C. The tissue frozen section was cut into 5 μm thick by freezing microtome (CM3050S, Leica, Germany). Fluorescence microscopic imaging of QDs was observed by a fluorescence microscope (Axio Observer, ZEISS, Germany).
Quantification of Uptake in Organs
Liver, spleen and kidney of each mouse were digested in the microwave digestion instrument by adding 4 mL 65% nitric acid (HNO3) and 1 mL 30% hydrogen peroxide (H2O2). The concentration of In in tissues was determined by ICP-MS. For all measurements, nitric acid blank and In standards was prepared and tested concurrently with test samples. Tissues from the control group at different post-injection time were dissolved in the similar manner. Concentration of In in the specific tissues was calculated using the following equations: [In] treated tissue (μg/g wet tissue) = [In] tissue suspension/wet weight of tissue.
Mice were sacrificed on Day1, Day 3, Day 7, Day 14 and Day 28 after the injection. Major organs including heart, liver, spleen, lung, kidney and brain were removed and fixed in tissue fixative. After gradient dehydration with different concentrations of alcohol in an automatic tissue dehydrator (APS300S, Leica, Germany), tissues were embedded in paraffin blocks by paraffin embedding station (Leica, Germany). Then, the tissues were cut into 5 μm thin slices by an ultra-thin semiautomatic microtome (RM2236, Leica, Germany) and adhered to the slides. After the slides were stained with hematoxylin and eosin (H&E), histopathological morphology was evaluated under the microscope (Axio Observer, ZEISS, Germany) by an independent pathologist unaware of the treatment.
After the mice were anaesthetized, blood samples were harvested from the posterior orbital venous plexus of mice. About 50 μL of blood was collected in tubes containing heparin sodium and routine blood analysis was determined by fully automatic five-classification hematology analyzer (BC5310, Mindray medical international limited, China). The specific hematology indexes in this study included white blood cell (WBC) count, neutrophils (Neu) percentage, lymphocyte (Lym) percentage, red blood cell (RBC) count, hematocrit (HCT), mean corpuscular volume (MCV), coefficient of variation of RBC volume distributing width (RDW-CV), hemoglobin concentration (HGB), mean corpuscular hemoglobin (MCH), platelet (PLT) count, thromboplastin (PCT), and mean platelet volume (MPV).
Serum Biochemical Analysis
The whole blood of mice was collected in disposable venous blood vessels containing separating gel and the serum was obtained by centrifugation for 15 mins at 4°C, 3500 rpm. The serum biochemical parameters were detected by automatic blood biochemical analyzer (BS-220, Mindray medical international limited, China). All matching reagents were purchased from Mindray medical international limited, China. The specific biochemical indexes in this study included alanine aminotransferase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), total protein (TP), albumin (ALB), globulin (GLB), the albumin and globulin ratio (A/G), total bilirubin (T-Bil), direct bilirubin (D-Bil), triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL-C), low-density lipoprotein (LDL-C), glucose (GLU), lactate dehydrogenase (LDH), creatine kinase (CK), creatine kinase isoenzyme (CK-MB), α-hydroxy butyrate dehydrogenase (α-HBDH), uric acid (UA), urea and creatinine (CREA).
All statistical analysis was performed by SPSS 22.0 statistical software packages and figures were drawn with GraphPad Prism software package. Data were expressed as mean ± standard deviation (SD). The difference among the different groups was compared by one-way ANOVA. Results were considered significant if P < 0.05.
Characterization of InP/ZnS QDs
TEM was used to evaluate the shape, size and morphology of the three types of InP/ZnS QDs with different surface functional groups (-OH, -NH2 and -COOH). The representative images of hQDs, aQDs and cQDs are shown in Figure 1(A-C), respectively, suggesting that the three kinds of InP/ZnS QDs were spherical or ellipsoidal, with a uniform particle size of approximately 3–7 nm. The diameter of aQDs was slightly smaller than that of hQDs and cQDs. The hydrodynamic size distribution and zeta potential of these three water-soluble InP/ZnS QDs were investigated by zeta potential and particle size analyzer. The results are shown in Figure 1(D-F) and Table 1. The hydrodynamic diameter of hQDs, aQDs and cQDs was (51.01 ±1.29) nm, (50.43 ± 2.03) nm, and (47.36 ± 1.85) nm, respectively. The zeta potential of the three water-soluble InP/ZnS QDs was -(21.03 ± 0.61) mV, -(21.63 ± 1.07) mV, and -(22.67 ± 0.15) mV. The optical properties of QDs were also evaluated and the results are shown in Figure 1(G-I). From the results of fluorescence spectra, the emission spectra of the three water-soluble QDs were narrow and symmetrical, and the emission peak was about at (625 ± 10) nm with the excitation at 380 nm. Evaluation of the absorbance spectra indicated the first exciton peak of the three InP/ZnS QDs was around at 330 nm. Based on the absorbance data, the direct band gap energy (Eg) of QDs was determined by Tauc’s relation,30 as αhv = α0(hv - Eg)1,2, where α0, hv, and Eg was a constant, photon energy and the band gap energy, respectively. Absorption coefficient (α) at different wavelengths was calculated from the absorption spectra. The values of Eg were determined by the linear region extrapolations of the curve of (αhv)2 vs hv.31,32 As illustrated in Figure S1, the Eg values of hQDs, aQDs and cQDs were 4.69, 3.81 and 3.65 eV, respectively.
Table 1 Particle Size, Hydrodynamic Diameter and Zeta Potential of These QDs
Body Weight and Organ Weight/BW Coefficients
The behavior, mental status, food intake, urine and feces of mice were observed daily after intravenous injection of QDs. Two mice from cQDs-treated group died on the first day after treatment. Besides, no unusual changes were observed in food intake, fur, behavior and mental status after exposure of QDs. The body weight of mice was continuously recorded for 28 days and the data was shown in Figure 2A. The body weight of QDs-exposed groups and the control group showed comparable increasing trends through the study. Main organs of mice were removed and weighted carefully when the mice were sacrificed at various post-injection times. Organ index of the main organs was calculated as organ weight (mg)/BW (g). The organ index of heart, liver, spleen, lung, kidney and brain of mice on Day 28 was shown in Figure 2B, there was no significant statistical difference in all organ index between QDs-treated groups and control group. The above results suggested that these InP/ZnS QDs did not interfere with the growth of mice.
Figure 2 Body weight and organ index in mice. (A) The body weight curve of mice continuously monitored for 28 days (Inset showed the magnified state of the body weight curve). (B) The main organ index of mice on Day 28 after administration.
Figure 3 Fluorescence images of main organ tissues of mice on Day1, Day 3, Day 7, Day 14 and Day 28 after treated with 25mg/kg BW hQDs (scale bar: 50 μm).
Figure 4 Fluorescence images of main organ tissues of mice on Day1, Day 3, Day 7, Day 14 and Day 28 after treated with 25mg/kg BW aQDs (scale bar: 50 μm).
Figure 5 Fluorescence images of main organ tissues of mice on Day1, Day 3, Day 7, Day 14 and Day 28 after treated with 25mg/kg BW cQDs (scale bar: 50 μm).
In vivo Distribution of QDs
After QDs enter the body through intravenous injection, they will be transported to various organs along with the blood stream. The distribution of QDs in main organs was observed by cryosection fluorescence microscopy. Fluorescence images of different tissues from mice treated with 25 mg/kg BW hQDs, aQDs and hQDs at indicated time points were shown in (Figures 3–5), respectively. Strong fluorescence of QDs could be observed in almost all tissue sections. Especially in the liver and spleen, QDs exhibited a bright and uniform punctate pattern. The PL intensity appeared to be weakening over time although the fluorescence signal still maintained in livers, spleens and kidneys. It should be noted that no fluorescence was observed in the tissue sections of the control group (data not shown). The results suggested that the three kinds of QDs could accumulate in the major organs of mice and keep their unique fluorescence characteristics for at least 28 days. Though very little fluorescence was observed in brain tissue sections after mice were exposed to QDs, it indicated that all three QDs could pass through the blood-brain barrier and distribute in the brain.
In order to further quantitate the accumulation of three kinds of QDs in liver, kidney and spleen, the In element concentration in tissues at different sampling times was measured by ICP-MS. The results were shown in Figure 6. The three QDs were mainly distributed in liver and spleen, and this result was consistent with that of cryosection fluorescence microscopy. The concentration of In in kidney was about one-tenth of that in liver and spleen. The accumulation of three QDs in the liver reached the peak on 3 days post-injection (hQDs: 7.95 μg/g In, aQDs: 9.06 μg/g In, and cQDs: 6.92 μg/g In). The distribution of aQDs and cQDs in spleen also reached the peak on Day 3 after administration, but In concentration of hQDs peaked in spleen at 7 days post-injection. After that, the In concentration in liver, spleen and kidney decreased gradually. However, In could be still detected in liver, spleen and kidney tissues from mice treated with high-dose QDs on Day 28. Since In was not detected in all tissues of the control group, it could be considered that all detected In element in liver, spleen and kidney came from the residues of QDs in vivo. The above results showed that the three QDs (hQDs, aQDs, and cQDs) were mainly distributed in the liver and spleen when they were injected intravenously. Although QDs may be removed or broken down in vivo, this process will take quite a long time.
Figure 6 The In element concentration in organs over a period of 28 days in mice following administration of three InP/ZnS QDs at 25 mg/kg BW. (A) Liver tissues. (B) Spleen tissues. (C) Kidney tissues.
Histopathological Detection Results
Histological assessment was performed to evaluate the tissue damage and inflammation caused by QDs exposure. Main organs of all mice were sliced into 5 μm sections and stained with H&E. The representative histological results are shown in Figure 7. After mice were intravenously injected different surface-functionalized QDs at the dose of 25 mg/kg BW or 2.5 mg/kg BW, no sign of inflammatory response or pathological changes was observed in heart, liver, spleen, lung, kidney, and brain of all mice at different sampling times when compared with the control group. Therefore, although all the three kinds of QDs could remain in the organs of mice, especially in liver and spleen for a long time, no obvious histopathological abnormalities were observed, which suggested InP/ZnS QDs with different surface functional groups (-OH, -NH2, and -COOH) caused low toxicity to these organs.
Since the three QDs will remain in vivo for a long time, the changes in blood cells can reflect some pathological reactions induced by QDs. Routine blood analysis was performed and the results are shown in Figure 8. Most of hematological parameters obtained from QDs-treated mice were comparable to those in control group. On the first day after treatment, WBC counts in aQDs and cQDs group were obviously higher than that in the control group (P < 0.05), which indicated that these two QDs may cause an acute inflammatory response after entering the body. The percent of Nue and Lym on Day 3 and Day 28 in aQDs groups was significantly higher than that in the control group (P < 0.05). The levels of RDW-CV on Day 3, PCT and MPV on Day 7 in hQDs group were remarkably higher than those in the control group (P < 0.05). The levels of PLT, PCT and MPV in cQDs groups were obviously changed compared to those of the control group (P < 0.05). No significant differences were found in the other parameters. The above results showed that a high dose of the three QDs caused changes in hematological indexes. In particular, aQDs and cQDs could cause acute inflammation in the body, hQDs mainly had adverse effects on red blood cells and platelets.
Serum Biochemical Analysis
Serum biochemistry tests were performed to observe the effects of InP/ZnS QDs on the biological functions of major organs. Liver function indexes including ALT, AST, ALP, TP, ALB, GLB, A/G, T-Bil, D-Bil, TG, TC, HDL-C, LDL-C, GLU were measured and the results are presented in Figure 9(A-N). In high-dose hQDs-treated groups, levels of TG and TC at 1, 3, 14 and 28 days post-injection were significantly higher than that in the control group (P < 0.05). Levels of T-Bil, D-Bil and LDL-C on Day 1, TP and HDL-C on Day 3, ALT and T-Bil on Day 14 were also obviously higher than that in control group (P < 0.05). In high-dose aQDs-treated groups, levels of ALP, A/G, D-Bil and LDL-C on Day1, ALP, ALB, TC on Day 3, TC on Day 28 were remarkably higher than that in control group (P < 0.05). In high-dose cQDs-treated groups, LDL-C on Day 1, A/G on Day 3 and GLU on Day 28 were obviously higher than that in control group (P < 0.05). Almost all the low-dose QD-exposed groups showed no significant changes in the above biochemical indexes. The results showed that the three kinds of surface-functionalized InP/ZnS QDs could affect the liver function of mice when exposed at high concentration, the effect of hQDs was the most serious, and the effect of aQDs and cQDs was relatively mild.
Heart function indexes including LHD, CK, CK-MB and α-HBDH of all mice were measured and the results are shown in Figure 9(O-R). Levels of LDH on Day 3 and Day 28, α-HBDH on Day 3 in high-dose hQDs-treated group were significantly higher than that in the control group (P < 0.05). Levels of α-HBDH on Day 7 and LDH on Day 14 in high-dose-aQDs-treated group were obviously higher than that in the control group (P < 0.05). There were no significant differences in CK and CK MB levels between QDs-treated groups and the control group. The above results showed that the hQDs and aQDs could cause slight effects on cardiac function, while cQDs had almost no effect on cardiac function. Furthermore, renal function indexes including UA, urea and CREA of all mice were also detected, and the results are shown in Figure 9(S-U). There were no significant changes in UA, urea and CREA levels of the three QDs-treated mice when compared with the control groups at the same sampling time. It illustrated that the three QDs with different surface functional groups had no toxicity to the kidney.
QDs are of great interest due to their unique optical and electronic properties, and have shown great potential applications in fluorescent probes, bioimaging, gene delivery and biosensors.33,34 However, the inherent toxicity of restricted heavy metals such as Cd, Pb severely hinders the clinical translation of QDs. Cd-free QDs alternatives are being widely investigated and InP QDs have shown a great potential as a replacement for CdSe QDs in applications. Therefore, it is vital to understand the biological fate and toxicity of InP QDs for its successful application in biological science. The toxicity of nanomaterials can be evaluated by both in vitro model and in vivo system. Up to now, there are very few studies on the toxicity of InP/ZnS QDs, which are carried out by in vitro cell lines35 or simple model organisms (Hydra vulgaris,36 rare minnow embryos22). As the biological aspects of animal models are very similar to human biology, it is an ideal model to systematically evaluate the toxicology of nanomaterials. As we all know, the in vivo toxicity of QDs is related to many factors, such as dosage, route of administration, exposure time, immune clearance ability of the body, etc. In terms of QDs themselves, the chemical–physical properties (such as chemical composition, size, shape, surface charge, surface modification, outer inorganic and organic shells, etc.) determine their efficacy and toxicity to a large extent. It is very important to comprehensively evaluate the disposition of nanoparticles in vivo, so as to understand and predict their effectiveness and side effects.37,38 In this study, we systematically studied the tissue biodistribution and in vivo toxicity of InP/ZnS QDs with different surface modifications (-OH, -NH2, -COOH) and different doses (2.5 mg/kg BW, 25 mg/kg BW) in BALB/c mice after a single intravenous injection, and we hope to fill in the gap of InP/ZnS QDs toxicity in vivo.
The biodistribution of QDs and the concentration of heavy metals released by QDs are the key parameters to evaluate their toxicity in vivo.39 Several studies have reported the biodistribution of different types of Cd-based QDs in mice or rat models. Haque et al reported that the fluorescence of CdSe/CdS-MPA QDs was able to be observed in the liver, spleen, lung and kidneys after repeated intraperitoneal injection into BALB/c mice. No histopathological changes were observed, but the level of IL-6 increased in plasma, liver and spleen.40 In this study, cryosection fluorescence microscopy and ICP-MS were utilized to detect the distribution of three surface functionalized InP/ZnS QDs in mice after a single intravenous injection at 25 mg/kg BW. Strong fluorescence of the three QDs could be observed in almost all tissue sections of main organs at 1 day post-injection. It suggested that all the three QDs could distribute in heart, liver, spleen, kidney, lung and brain along with blood circulation and kept their unique fluorescence characteristics. QDs were excreted or broken down over time, but their fluorescence could still be observed in the liver and spleen on Day 28. The results of ICP-MS were consistent with those of fluorescence imaging. The three QDs were mainly distributed in liver and spleen. The concentration of In in kidney was about one-tenth of that in liver and spleen. When nanoparticles entered the physiological environment, their physical and chemical properties or integrity may change significantly following protein binding, biomolecular corona formation or cell internalization.41,42 Liu et al reported that CdTe/ZnS QDs were chemically stabilized and could not elicit biological responses in vitro, but they would undergo degradation in vivo, since the Cd:Te ratio gradually decreased with time compared with the intact CdTe/ZnS QDs from 6 hrs after injection.43 Some published research have reported Cd-based QDs can lead to reduced cell survival, production of reactive oxygen species (ROS), DNA damage, mitochondrial damage or cell death in multiple cell lines,44,45 and can induce liver morphological and functional impairments, lung inflammation and injury in vivo experiments.46,47 As Cd2+ can be released via the oxidation of QDs, and then bound to sulfhydryl groups on proteins in cells, which leads to the functional degradation of various subcellular organelles, the release of Cd2+ is recognized as one of the main reasons for the toxicity of Cd-based QDs.48 Compared with II–VI semiconductors, III–V semiconductors nanocrystals (particularly InP) have better structural robustness and stability which are attributed to the presence of covalent bonds in their matrix. Since the covalent bonding degree in InP nanocrystals is greater than that in II–VI semiconductors such as CdSe and CdTe, InP QDs are less likely to be degraded and release heavy metals in biological systems.17,18
In this study, the fluorescence of QDs appeared to be weakening over time, but it could still be observed on 28 days post-injection, indicating that there were still intact QDs in tissues. There are two possible reasons for the weakening of fluorescence. Firstly, the integrity of QDs was broken after they entered the body because of the corrosive internal environment.49 Once the QDs were destroyed, the surface trap states produced on the particles and affected the electron–hole recombination process, and eventually lead to the decrease or disappearance of fluorescence intensity. Although the structural stability of InP QDs is better than Cd-based QDs, a recent study by Veronesi has reported that InP core was rapidly degraded in Hydra tissues without evident toxicity.50 Another reason is that QDs were excreted through kidneys, bile ducts, lungs, secretory glands or other organs. It is generally believed that nanoparticles with a diameter less than 3 nm can extravasate into tissues nonspecifically. Nanoparticles with a diameter less than 5.5 nm can be excreted via renal clearance rapidly and efficiently, while the nanoparticles with a diameter more than 15 nm are hardly cleared via the urinary excretion.51,52 As the fluorescence signal of cryosection fluorescence microscopy is easy to be interfered by environmental factors and tissue autofluorescence, In concentration of the three organs (liver, spleen and kidney) with the larger amount of QDs distribution was detected by ICP-MS on the basis of fluorescence imaging to reflect the existence of QDs in tissues. The In concentration of the three QDs reached the peak in liver and spleen 3–7 days after entering the body, but there were two peaks in the kidney, Day 3 and Day 14. It showed that a portion of QDs was excreted through renal clearance in the first three days after injected into body. Some portion of QDs were driven to kidney along with body fluids circulation and then excreted by the kidney. The three QDs still remained in the tissues on Day 28 from the results of ICM-MS and fluorescence imaging, which revealed both the excretion and degrading of QDs need quite a long time. Fitzpatrick et al reported the fluorescence of CdSe/ZnS QDs could be retained and existed in nude mice for up to 2 years using both whole-body and microscopic fluorescence techniques.53 Yaghin et al reported the carboxylated In-based QDs could remain in liver and spleen tissues of rat for up to 90 days after intravenous injection at a dose of 12.5 mg/kg BW.19
Surface functionalization of nanoparticles is one of the critical steps to improve their physical and chemical properties for better applications. The change itself may bring potential risks and cause harm to the biological system.54,55 InP QDs are recognized as the low-toxic or non-toxic substitutes for Cd-based QDs. It is necessary to evaluate the safety of InP QDs with different surface modifications before practical applications. It is worth noting that InP/ZnS QDs with different surface functional groups (-OH, -NH2, and -COOH) could exist in vivo for quite a long time from both the results of ICP-MS and fluorescence imaging, more attention should be paid to the toxic reaction caused by their distribution and accumulation. In this study, the toxicity of three InP/ZnS QDs with different surface functional groups were systematically investigated in mice following intravenous injection at either 2.5 mg/kg or 25 mg/kg (n=7). Histopathology of main organs, the hematological indexes and biochemical indexes of all mice were performed at different predetermined time (at 1, 3, 7, 14, and 28 days post-injection). Throughout the whole study, besides two mice died on Day 1 after treated with 25 mg/kg cQDs, no unusual behavior or responses were observed in QDs-treated mice compared to control mice. The results of histopathological examination showed that no obvious histopathological abnormalities were observed in the main organs (including heart, liver, spleen, lung, kidney, and brain) of all mice at different sampling time after intravenously injected different surface-functionalized QDs. From the results of hematology analysis, high dose of aQDs and cQDs could cause acute inflammation in the body, while hQDs mainly had adverse effects on red blood cells and platelets. Rehberg et al reported that carboxyl-QDs and amine-QDs could induce leukocyte recruitment in vivo through affecting their localization in postcapillary venules, their uptake by perivascular macrophages, and their potential to modify steps of leukocyte recruitment.56,57 From the results of biochemical analysis, the three QDs could affect the liver function of mice, the effect of hQDs was the most serious, and the effect of aQDs and cQDs was relatively mild. High dose of hQDs and aQDs could cause slight effects on cardiac function, while cQDs had almost no effect on cardiac function. No renal function was changed in all mice after exposed the three QDs. Moreover, the three InP/ZnS QDs with exposure concentration of 2.5mg/kg BW showed no obvious toxicity on liver function, renal function and cardiac function in mice at different sampling times. Although the long-term accumulation of the three QDs with high exposure dose in vivo caused the changes of biochemical indexes of liver function and cardiac function, it did not cause histopathological abnormalities to the main organs, nor significantly change the growth and living habits of mice.
In summary, the toxicology and biodistribution of InP/ZnS QDs modified with -OH, -NH2 or -COOH groups were systematically investigated in mice for a 28-day observation period after a single intravenous injection. The three kinds of InP/ZnS QDs could be rapidly distributed into the main organs of mice, especially in the liver and spleen, and were excreted from the body gradually. The In element from QDs still could be detected in liver, spleen and kidney over a 28-day period. Low dose exposure of three QDs hardly caused obvious toxicity, while high-dose exposure could cause some changes in hematological or biochemical parameters but had no effect on histopathological changes. It should be noted that high-dose exposure of cQDs could lead to death, acute inflammatory reaction and slight changes in liver function in mice, which was considered to be more toxic compared with the other two QDs. Different surface modifications are crucial to the in vivo toxicity of QDs, which need to be taken into consideration in the synthesis and application of QDs in the future. Even though it will take quite a long time to realize the clinical transformation of QDs, we still hope that QDs can give full play in biological application with the rapid development of chemical synthesis technology, nano application and toxicology technology.
QDs, quantum dots; InP, Indium phosphide; PL, photoluminescence; NIR, near infrared; BW, body weight; In, Indium; hQDs, hydroxylated QDs; aQDs, amino; cQDs, carboxylic QDs; TEM, transmission electron microscopy; OCT, optimal cutting temperature compound; WBC, white blood cell; Neu, neutrophils; Lym, lymphocyte; RBC, red blood cell; HCT, hematocrit; MCV, mean corpuscular volume; RDW-CV, coefficient of variation of RBC volume distributing width; HGB, hemoglobin concentration; MCH, mean corpuscular hemoglobin; PLT, platelet; PCT, thromboplastin; MPV, mean platelet volume; ALT, alanine aminotransferase; AST, aspartate transaminase; ALP, alkaline phosphatase; TP, total protein; ALB, albumin; GLB, globulin; A/G, the albumin and globulin ratio; T-Bil, total bilirubin; D-Bil, direct bilirubin; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein; LDL-C, low-density lipoprotein; GLU, glucose; LDH, lactate dehydrogenase; CK, creatine kinase; CK-MB, creatine kinase isoenzyme; α-HBDH, α-hydroxy butyrate dehydrogenase; UA, uric acid; CREA, creatinine; SD, standard deviation; ICP-MS, inductively coupled plasma mass spectrometry.
The work is supported by grants from the National Natural Science Foundation of China (NSFC) (No. 21677102, 31671491 and 61935012), Shenzhen Science and Technology project (No. JCYJ20170817093725277), Shenzhen International Cooperation Project (No. GJHZ20170313111237888). The authors also thank the Instrumental Analysis Center of Shenzhen University.
The authors report no conflicts of interest in this work.
1. Chan WCW, Maxwell DJ, Gao XH, et al. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol. 2002;13(1):40–46. doi:10.1016/S0958-1669(02)00282-3
2. Zarco-Fernandez S, Coto-Garcia AM, Munoz-Olivas R, et al. Bioconcentration of ionic cadmium and cadmium selenide quantum dots in zebrafish larvae. Chemosphere. 2016;148:328–335. doi:10.1016/j.chemosphere.2015.12.077
3. Hemmateenejad B, Shamsipur M, Samari F, et al. Study of the interaction between human serum albumin and Mn-doped ZnS quantum dots. J Iran Chem Soc. 2015;12(10):1729–1738. doi:10.1007/s13738-015-0647-3
4. Das P, Ganguly S, Maity PP, et al. Converting waste Allium sativum peel to nitrogen and sulphur co-doped photoluminescence carbon dots for solar conversion, cell labeling, and photobleaching diligences: a path from discarded waste to value-added products. J Photoch Photobio B. 2019;197:111545. doi:10.1016/j.jphotobiol.2019.111545
5. Jain S, Bharti S, Bhullar GK, et al. pH dependent drug release from drug conjugated PEGylated CdSe/ZnS nanoparticles. Mater Chem Phys. 2020;240:122162. doi:10.1016/j.matchemphys.2019.122162
6. Das P, Bose M, Das AK, et al. One-step synthesis of fluorescent carbon dots for bio-labeling assay. Macromol Symp. 2018;382(1):6. doi:10.1002/masy.201800077
7. Li L, Yin DH, Xu K, et al. A sandwich immunoassay for brucellosis diagnosis based on immune magnetic beads and quantum dots. J Pharm Biomed Anal. 2017;141:79–86. doi:10.1016/j.jpba.2017.03.002
8. Rajabi HR, Shamsipur M, Khosravi AA, et al. Selective spectrofluorimetric determination of sulfide ion using manganese doped ZnS quantum dots as luminescent probe. Spectrochim Acta A Mol Biomol Spectrosc. 2013;107:256–262. doi:10.1016/j.saa.2013.01.045
9. Shamsipur M, Rajabi HR. Pure zinc sulfide quantum dot as highly selective luminescent probe for determination of hazardous cyanide ion. Mater Sci Eng C Mater Biol Appl. 2014;36:139–145. doi:10.1016/j.msec.2013.12.001
10. Rajabi HR, Shahrezaei F, Farsi M. Zinc sulfide quantum dots as powerful and efficient nanophotocatalysts for the removal of industrial pollutant. J Mater Sci-Mater El. 2016;27(9):9297–9305. doi:10.1007/s10854-016-4969-4
11. Rajabi HR, Karimi F, Kazemdehdashti H, et al. Fast sonochemically-assisted synthesis of pure and doped zinc sulfide quantum dots and their applicability in organic dye removal from aqueous media. J Photochem Photobio B. 2018;181:98–105. doi:10.1016/j.jphotobiol.2018.02.016
12. Lin GM, Li L, Panwar N, et al. Non-viral gene therapy using multifunctional nanoparticles: status, challenges, and opportunities. Coord Chem Rev. 2018;374:133–152. doi:10.1016/j.ccr.2018.07.001
13. Yadav R, Madhukar Chaudhary P, Subramani B, et al. Imaging and targeting of the alpha(2-6) and alpha(2-3) linked sialic acid quantum dots in zebrafish and mouse models. ACS Appl Mater Interfaces. 2018;10(34):28322–28330. doi:10.1021/acsami.8b07668
14. Li D, Kristal B, Wang YJ, et al. Enhanced efficiency of InP-based red quantum dot light-emitting diodes. ACS Appl Mater Interfaces. 2019;11(37):34067–34075. doi:10.1021/acsami.9b07437
15. Ranjbar-Navazi Z, Omidi Y, Eskandani M, et al. Cadmium-free quantum dot-based theranostics. Trac-Trend Anal Chem. 2019;118:386–400. doi:10.1016/j.trac.2019.05.041
16. Zhang L, Yang XQ, An J, et al. In vivo tumor active cancer targeting and CT-fluorescence dual-modal imaging with nanoprobe based on gold nanorods and InP/ZnS quantum dots. J Mater Chem B. 2018;6(17):2574–2583. doi:10.1039/c7tb02643a
17. Bharali DJ, Lucey DW, Jayakumar H, et al. Folate-receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy. J Am Chem Soc. 2005;127(32):11364–11371. doi:10.1021/ja051455x
18. Yong KT, Ding H, Roy I, et al. Imaging pancreatic cancer using bioconjugated InP quantum dots. ACS Nano. 2009;3(3):502–510. doi:10.1021/nn8008933
19. Yaghini E, Turner H, Pilling A, et al. In vivo biodistribution and toxicology studies of cadmium-free indium-based quantum dot nanoparticles in a rat model. Nanomedicine: NBM. 2018;14(8):2644–2655. doi:10.1016/j.nano.2018.07.009
20. Brunetti V, Chibli H, Fiammengo R, et al. InP/ZnS as a safer alternative to CdSe/ZnS core/shell quantum dots: in vitro and in vivo toxicity assessment. Nanoscale. 2013;5(1):307–317. doi:10.1039/c2nr33024e
21. Yamazaki K, Tanaka A, Hirata M, et al. Long term pulmonary toxicity of indium arsenide and indium phosphide instilled intratracheally in hamsters. J Occup Health. 2000;42(4):169–178. doi:10.1539/joh.42.169
22. Chen Y, Yang Y, Ou F, et al. InP/ZnS QDs exposure induces developmental toxicity in rare minnow (Gobiocypris rarus) embryos. Environ Toxicol Pharmacol. 2018;60:28–36. doi:10.1016/j.etap.2018.04.005
23. Yu L, Tian X, Gao D, et al. Oral administration of hydroxylated-graphene quantum dots induces intestinal injury accompanying the loss of intestinal stem cells and proliferative progenitor cells. Nanotoxicology. 2019;13:1–13. doi:10.1080/17435390.2019.1668068
24. Murase N, Horie M, Sawai T, et al. Silica layer-dependent leakage of cadmium from CdSe/ZnS quantum dots and comparison of cytotoxicity with polymer-coated analogues. J Nanopart Res. 2019;21(1):10. doi:10.1007/s11051-018-4449-2
25. Zheng H, Mortensen LJ, Ravichandran S, et al. Effect of nanoparticle surface coating on cell toxicity and mitochondria uptake. J Biomed Nanotechnol. 2017;13(2):155–166. doi:10.1166/jbn.2017.2337
26. Liu J, Hu R, Liu JW, et al. Cytotoxicity assessment of functionalized CdSe, CdTe and InP quantum dots in two human cancer cell models. Mater Sci Eng C Mater Biol Appl. 2015;57:222–231. doi:10.1016/j.msec.2015.07.044
27. Du Y, Zhong YY, Dong JJ, et al. The effect of PEG functionalization on the in vivo behavior and toxicity of CdTe quantum dots. RSC Adv. 2019;9(22):12218–12225. doi:10.1039/c9ra00022d
28. Song JJ, Dai Z, Guo WJ, et al. Preparation of CdTe/CdS/SiO2 core/multishell structured composite nanoparticles. J Nanosci Nanotechnol. 2013;13(10):6924–6927. doi:10.1166/jnn.2013.8064
29. Tang XZ, Sun J, Ge T, et al. PEGylated liposomes as delivery systems for Gambogenic acid: characterization and in vitro/in vivo evaluation. Colloids Surf. B: Biointerfaces. 2018;172:26–36. doi:10.1016/j.colsurfb.2018.08.022
30. Tauc J. Optical Properties of Solids. New York: Academic Press Inc; 1966. doi:10.1016/C2013-0-07656-6.
31. Rajabi HR, Farsi M. Quantum dot based photocatalytic decolorization as an efficient and green strategy for the removal of anionic dye. Mater Sci Semicond Process. 2015;31:478–486. doi:10.1016/j.mssp.2014.11.044
32. Karimi F, Rajabi HR, Kavoshi L. Rapid sonochemical water-based synthesis of functionalized zinc sulfide quantum dots: study of capping agent effect on photocatalytic activity. Ultrason Sonochem. 2019;57:139–146. doi:10.1016/j.ultsonch.2019.05.019
33. Das P, Ganguly S, Banerjee S, et al. Graphene based emergent nanolights: a short review on the synthesis, properties and application. Res Chem Intermediat. 2019;45(7):3823–3853. doi:10.1007/s11164-019-03823-2
34. Ganguly S, Das P, Banerjee S, et al. Advancement in science and technology of carbon dot-polymer hybrid composites: a review. Funct Compos Struct. 2019;1(2):022001. doi:10.1088/2631-6331/ab0c80
35. Chen T, Li L, Xu GX, et al. Cytotoxicity of InP/ZnS quantum dots with different surface functional groups toward two lung-derived cell lines. Front Pharmacol. 2018;9:763. doi:10.3389/fphar.2018.00763
36. Allocca M, Mattera L, Bauduin A, et al. An integrated multilevel analysis profiling biosafety and toxicity induced by indium- and cadmium-based quantum dots in vivo. Environ Sci Technol. 2019;53(7):3938–3947. doi:10.1021/acs.est.9b00373
37. Xie YC, Wan B, Yang Y, et al. Cytotoxicity and autophagy induction by graphene quantum dots with different functional groups. J Environ Sci-China. 2019;77:198–209. doi:10.1016/j.jes.2018.07.014
38. Zhao Y, Sultan D, Liu Y. Biodistribution, excretion, and toxicity of nanoparticles. Theranostic Bionanomater. 2019:27–53. doi:10.1016/B978-0-12-815341-3.00001-8.
39. Song YK, Wu YY, Wang HT, et al. Carbon quantum dots from roasted Atlantic salmon (Salmo salar L.): formation, biodistribution and cytotoxicity. Food Chem. 2019;293:387–395. doi:10.1016/j.foodchem.2019.05.017
40. Haque MM, Im HY, Seo JE, et al. Acute toxicity and tissue distribution of CdSe/CdS-MPA quantum dots after repeated intraperitoneal injection to mice. J Appl Toxicol. 2013;33(9):940–950. doi:10.1002/jat.2775
41. Kreyling WG, Abdelmonem AM, Ali Z, et al. In vivo integrity of polymer-coated gold nanoparticles. Nat Nanotechnol. 2015;10(7):619–623. doi:10.1038/Nnano.2015.111
42. Docter D, Westmeier D, Markiewicz M, et al. The nanoparticle biomolecule corona: lessons learned - challenge accepted? Chem Soc Rev. 2015;44(17):6094–6121. doi:10.1039/c5cs00217f
43. Liu N, Mu Y, Chen Y, et al. Degradation of aqueous synthesized CdTe/ZnS quantum dots in mice: differential blood kinetics and biodistribution of cadmium and tellurium. Part Fibre Toxicol. 2013;10:37. doi:10.1186/1743-8977-10-37
44. Duong HD, Yang S, Seo YW, et al. Effects of CdSe and CdSe/ZnS core/shell quantum dots on singlet oxygen production and cell toxicity. J Nanosci Nanotechnol. 2018;18(3):1568–1576. doi:10.1166/jnn.2018.15305
45. Wu GZ, Chen X, Ma XY, et al. Toxicity evaluation of CdSe nanorods on macrophages and the protective effect of resveratrol. J Nanopart Res. 2019;21(2):38. doi:10.1007/s11051-019-4473-x
46. Lu YH, Xu SC, Chen HY, et al. CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation. Biomaterials. 2016;90:27–39. doi:10.1016/j.biomaterials.2016.03.003
47. Roberts JR, Antonini JM, Porter DW, et al. Lung toxicity and biodistribution of Cd/Se-ZnS quantum dots with different surface functional groups after pulmonary exposure in rats. Part Fibre Toxicol. 2013;10:5. doi:10.1186/1743-8977-10-5
48. Mo D, Hu L, Zeng GM, et al. Cadmium-containing quantum dots: properties, applications, and toxicity. Appl Microbiol Biotechnol. 2017;101(7):2713–2733. doi:10.1007/s00253-017-8140-9
49. Soenen SJ, Montenegro JM, Abdelmonem AM, et al. The effect of nanoparticle degradation on poly(methacrylic acid)-coated quantum dot toxicity: the importance of particle functionality assessment in toxicology. Acta Biomater. 2014;10(2):732–741. doi:10.1016/j.actbio.2013.09.041
50. Veronesi G, MorosIl M, Castillo-Michel H, et al. In vivo biotransformations of indium phosphide quantum dots revealed by X-ray microspectroscopy. ACS Appl Mater Interfaces. 2019;11(39):35630–35640. doi:10.1021/acsami.9b15433
51. Choi HS, Liu W, Misra P, et al. Renal clearance of quantum dots. Nat Biotechnol. 2007;25(10):1165–1170. doi:10.1038/nbt1340
52. Li MG, Al-Jamal KT, Kostarelos K, et al. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano. 2010;4(11):6303–6317. doi:10.1021/nn1018818
53. Fitzpatrick JAJ, Andreko SK, Ernst LA, et al. Long-term persistence and spectral blue shifting of quantum dots in vivo. Nano Lett. 2009;9(7):2736–2741. doi:10.1021/nl901534q
54. Wu K, Su DQ, Liu JM, et al. Magnetic nanoparticles in nanomedicine: a review of recent advances. Nanotechnology. 2019;30(50):502003. doi:10.1088/1361-6528/ab4241
55. Tang Y, Han S, Liu H, et al. The role of surface chemistry in determining in vivo biodistribution and toxicity of CdSe/ZnS core-shell quantum dots. Biomaterials. 2013;34(34):8741–8755. doi:10.1016/j.biomaterials.2013.07.087
56. Rehberg M, Praetner M, Leite CF, et al. Quantum dots modulate leukocyte adhesion and transmigration depending on their surface modification. Nano Lett. 2010;10(9):3656–3664. doi:10.1021/nl102100m
57. Rehberg M, Leite CF, Mildner K, et al. Surface chemistry of quantum dots determines their behavior in postischemic tissue. ACS Nano. 2012;6(2):1370–1379. doi:10.1021/nn204187c
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.